Home / Health / WellSpan & Johns Hopkins Boost Cancer Care
WellSpan & Johns Hopkins Boost Cancer Care
21 Aug
Summary
- Oncology collaboration renewed to expand patient access to advanced care.
- Over 1,300 patients received support across 12 cancer sub-specialties.
- Nearly 500 patients enrolled in clinical trials through the partnership.
WellSpan Health and Johns Hopkins Medicine have renewed their long-standing oncology collaboration, marking a significant expansion of advanced cancer care access throughout central Pennsylvania. This partnership, initially formed in 2017 and expanded in 2021, has already provided crucial support to over 1,300 WellSpan patients across 12 cancer sub-specialties.
Furthermore, approximately 500 WellSpan patients have benefited from enrolling in clinical trials coordinated by Johns Hopkins Medicine. This renewed commitment emphasizes a shared vision of integrating academic medical center strengths with community-based programs to deliver superior oncology services.
Future initiatives include investments in oncology services at WellSpan Evangelical Community Hospital, introducing local infusion and eventually radiation oncology services. This expansion aims to bring cutting-edge cancer expertise closer to patients, allowing them to remain within their support systems.
